Market Access News | pharmaphorum

News

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after Merck & Co’s Belsomra, which made its debut there in 2014.

News

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

GlaxoSmithKline and Sanofi are close to agreeing a £500m deal to supply the UK government with 60 million doses of their potential coroanvirus vaccine, according to a press report.

News

ViiV gets FDA nod for Rukobia drug for older HIV patients

The FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who have been on antiretroviral therapy (ART) for so long it is sta

News

All EU Flags in front of the European Parliament, Flags in front of the European Parliament, Strasbourg, Alsace, France

Survey shows patients wait six times longer than EU neighbou...

Patients in some European countries are waiting up to six times longer for access to medicines than their neighbours, according to a survey by Europe’s pharma trade body.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Novartis pays $678 million to settle US kickback allegations

Another nail has been hammered into the coffin of the pharma model of providing lavish entertainment and other benefits to doctors to encourage prescribing of medicines.

News

US government buys most of world's supply of COVID-19 drug r...

The US government has acquired most of the global supply of Gilead’s COVID-19 drug remdesivir until September as health secretary Alex Azar said that president Donald Trump had struck an "

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

GSK and Sanofi close in on £500m COVID-19 vaccine deal with ...

ViiV gets FDA nod for Rukobia drug for older HIV patients

Survey shows patients wait six times longer than EU neighbou...

Novartis pays $678 million to settle US kickback allegations

US government buys most of world's supply of COVID-19 drug r...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks